An investigation for investors in Zafgen Inc (NASDAQ: ZFGN) shares over potential securities laws violations by Zafgen Inc was announced.
San Diego, CA -- (SBWIRE) -- 04/15/2019 -- An investigation was announced over potential securities laws violations by Zafgen Inc in connection with certain financial statements.
Investors who purchased shares of Zafgen Inc (NASDAQ: ZFGN), have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Zafgen Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Boston, MA based Zafgen, Inc., a clinical-stage biopharmaceutical company, develops therapies for patients suffering from metabolic diseases comprising type 2 diabetes, Prader-Willi syndrome (PWS), and liver diseases. On March 11, 2019, Zafgen Inc announced its decision to suspend plans to file an investigational new drug application forZGN-1258,the Company's candidate for rare metabolic disorders based on a finding in rodent toxicology studies. According to Zafgen Inc, data showed degeneration and other anomalies in rat muscle tissue to different degrees in both vehicle and dose arms of the studies.
Those who purchased shares of Zafgen Inc (NASDAQ: ZFGN) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels